Trial intelligence / Profile preview

Whole Brain Radiotherapy and Thiotepa Intrathecal Injection for Solid Tumor Leptomeningeal Metastasis

NCT06376292Phase 2Completed

Sponsor
Second Affiliated Hospital of Zhejiang University School of Medicine
Start
Jan 2024
Primary completion
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of thiotepa in leptomeningeal metastasis (LM), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Jan 2024; status: completed.

02

Drugs

thiotepa
03

Conditions

leptomeningeal metastasis (LM)

Beyond the preview

Go deeper on NCT06376292.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06376292.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call